News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis India Limited (NVS) Plans To Sell Rifampicin Business To Sandoz



10/19/2005 5:12:34 PM

New Delhi, January 28, 2005|17:43 IST-- Pharma company Novartis India Ltd on Friday said it intends to sell its anti-TB rifampicin bulk drug business together with its Mahad facility to Sandoz Pvt Ltd for an estimated amount of Rs 30.77 crore.

Read at Hindustan Times
Read at ProPublica


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES